Skip to main content
Log in

Dupilumab

Ocular surface disease successfully treated with lifitegrast: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Zirwas MJ, et al. Lifitegrast add-on treatment for dupilumab-induced ocular surface disease (DIOSD): A novel case report. JAAD Case Reports 5: 34-36, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1016/j.jdcr.2018.10.016 - USA

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dupilumab. Reactions Weekly 1734, 195 (2019). https://doi.org/10.1007/s40278-019-56320-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-56320-7

Navigation